Core C: Clinical Support/Biostatistics will provide the Program Project investigators with resources necessary for the performance of clinical studies, including Pilot/Phase I vaccination protocols. The objectives of the Core are: (a) to identify patients who are candidates for participation in clinical trials; (b) to implement therapeutic and monitoring procedures for patients on clinical protocols according to the protocol requirements; (c) to provide basic researchers participating in the Program Project with adequate clinical materials to fulfill the objectives of the Program and facilitate the development of vaccines against squamous cell carcinoma of the oral cavity; (d) to provide research design, data management, data analysis, and biostatistical consultative support to all program investigators: (e) to assist the program investigators in the development of nested clinical protocols based on new data generated in the initial phase of the Program; (f) to help investigators in the preparation of summaries, abstracts, presentations and manuscripts. The core will support clinical and research activities of the Program by utilizing expertise and resources existing in the Departments of Otolaryngology, University of Pittsburgh and the UPCI Division of Medical Oncology and the Biostatistics Facility.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Program Projects (P01)
Project #
2P01DE012321-06
Application #
6541379
Study Section
Special Emphasis Panel (ZDE1-PW (04))
Project Start
1997-09-01
Project End
2007-08-31
Budget Start
1997-09-01
Budget End
2007-08-31
Support Year
6
Fiscal Year
2002
Total Cost
$78,363
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Whiteside, Theresa L; Ferris, Robert L; Szczepanski, Miroslaw et al. (2016) Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma. Head Neck 38 Suppl 1:E494-501
Visus, Carmen; Ito, Diasuke; Dhir, Rajiv et al. (2011) Identification of Hydroxysteroid (17?) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas. Cancer Immunol Immunother 60:919-29
Hoffmann, Thomas K; Trellakis, Sokratis; Okulicz, Kornelia et al. (2011) Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck. Anticancer Res 31:3151-7
Visus, Carmen; Wang, Yangyang; Lozano-Leon, Antonio et al. (2011) Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8? T cells. Clin Cancer Res 17:6174-84
Mandapathil, Magis; Hilldorfer, Benedict; Szczepanski, Miroslaw J et al. (2010) Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J Biol Chem 285:7176-86
Andrade Filho, Pedro A; Ito, Daisuke; Deleo, Albert B et al. (2010) CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 59:1561-8
Czystowska, Malgorzata; Strauss, Laura; Bergmann, Christoph et al. (2010) Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2). J Mol Med (Berl) 88:577-88
Macatangay, Bernard J C; Szajnik, Marta E; Whiteside, Theresa L et al. (2010) Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART. PLoS One 5:e9852
Albers, Andreas E; Schaefer, Carsten; Visus, Carmen et al. (2009) Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer. Head Neck 31:773-81
Chikamatsu, Kazuaki; Sakakura, Koichi; Takahashi, Goro et al. (2009) CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer. Cancer Immunol Immunother 58:1441-8

Showing the most recent 10 out of 94 publications